Merck & Co., Inc. (NYSE:MRK) is projected to declare fiscal fourth quarter financial results right before the stock market’s official open on February 02, 2017. The stock showed no change about 0 percent in price since last results when it was at $60.29 a share. Based on the most relevant past-periods data, there is an 51.85 percent probability for this firm’s share price to go down following next quarterly results. Earnings reaction history tells us that the equity price moved down 14 times out of last 27 reported quarters. It has beaten earnings-per-share estimates 91% of the time in its last 12 earnings reports. It fell short of earnings estimates on 1 occasions, and it has met expectations 0 time.
Here’s how traders responded to MRK earnings announcements over the past few quarters.
Merck & Co., Inc. (MRK) Earnings Surprises & Reaction
Given its history, the average earnings announcement surprise was 4.3 percent over the past four quarters. Back on October 25, 2016, it posted earnings per-share earnings at $1.07 which beat the consensus $0.98 projection (positive surprise of9.18%. For the quarter, revenue came in at 10.54B versus consensus estimate of 10.18B. The stock gained 1.97 percent the session following the earnings reports were released, and on 7th day price change was -3.33 percent.
On July 29, 2016, it reported earnings at $0.93 a share compared with the consensus estimate of $0.92 per share (positive surprise of 1.09%). Revenue of 9.84B for that quarter was above the $9.78B analysts had expected. The stock climbed 0.4% the day following the earnings announcement, and on 7th day price change was -1.01%.
On May 5, 2016, it recorded $0.89 a share in earnings which topped the consensus estimate of $0.85 (positive surprise of 4.71%). Revenue for the quarter was $9.31B while analysts called for revenues to be $9.46B. The stock dropped -1.33% the day following the earnings data was made public, and on 7th day price change was -0.91%.
On February 3, 2016, it announced earnings per share at $0.93 versus the consensus estimate of $0.91 per share (positive surprise of 2.2%). That came on revenues of $10.22B for that period. Analysts had expected $10.35B in revenue.
Merck & Co., Inc. Earnings Estimates
As Q4 earnings announcement date approaches, Wall Street is expecting earnings per share of $0.91. The analysts’ present consensus range is $0.88-$0.93 for EPS. The market consensus range for revenue is between $9.06B and $9.73B, with an average of $9.41B.
Merck & Co., Inc. (NYSE:MRK) last ended at $61.1, sending the company’s market cap near $168.46B. The consensus 12-month price target from analysts covering the stock is $67.28. The share price has declined -5.94% from its top level in 52 weeks and dropped 3.79% this year. It recently traded in a range of $60.08-$61.48 at a volume of 9727324 shares. The recent trading ended with the price nearly 3.79 higher for the last 5 trading days, rebounding 31.49% from its 52-week low.